The latter enrolled 190 patients with obesity (mean age 54.4 years, mean BMI 36.1 kg/m 2 ) and biopsy-proven MASH and moderate-to-severe fibrosis regardless of the presence of T2D, showing a BW reduction of 10.7%, 13.3%, 15.6% and 0.8% at 52 weeks with tirzepatide 5 mg, 10 mg, 15 mg and placebo, respectively 39
Metabolismo dei grassi: Supporta la "combustione" dei grassi, contribuendo alla gestione del peso corporeo e alla definizione muscolare
doi: 10.1080/095530099139656
It is also one of the Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs), such as Zoloft (sertraline) and Cymbalta (duloxetine), are common treatment options for anxiety
Rarely, GLP-1 receptor agonists have been associated with acute pancreatitis